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Abstract
Mathematical models of mitochondrial bioenergetics provide powerful analytical tools to help interpret experimental data
and facilitate experimental design for elucidating the supporting biochemical and physical processes. As a next step
towards constructing a complete physiologically faithful mitochondrial bioenergetics model, a mathematical model was
developed targeting the cardiac mitochondrial bioenergetic based upon previous efforts, and corroborated using both
transient and steady state data. The model consists of several modified rate functions of mitochondrial bioenergetics,
integrated calcium dynamics and a detailed description of the K+-cycle and its effect on mitochondrial bioenergetics and
matrix volume regulation. Model simulations were used to fit 42 adjustable parameters to four independent experimental
data sets consisting of 32 data curves. During the model development, a certain network topology had to be in place and
some assumptions about uncertain or unobserved experimental factors and conditions were explicitly constrained in order
to faithfully reproduce all the data sets. These realizations are discussed, and their necessity helps contribute to the
collective understanding of the mitochondrial bioenergetics.
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manner so that a data-compatible, semi-mechanistic description
of the underlying bioenergetic processes emerges. With the addition
of each new experimental data set, the model matures either
through corroboration via evidence that supports the hypothesized
mechanisms encoded within the mathematical representation or
through modification of the model structure and parameters to
refine and/or reveal more insights and alter the supporting
hypothesized mechanisms underlying bioenergetic processes.
Several mathematical models have been developed [1–6] to
describe aspects of mitochondrial bioenergetics, but none currently
capture the complete dynamics of all metabolically relevant ion
and substrate regulatory functions observed during physiological
and pathophysiological conditions. As the next step towards
constructing a complete physiologically faithful mitochondrial
bioenergetics model, this manuscript describes the development
and corroboration of a mathematical model based on cardiac
mitochondria that builds upon these previously published models.
The Yugi and Tomita model [6] simulates mitochondrial
bioenergetics with the most breadth. They have compiled a large
mitochondrial bioenergetics model that qualitatively captures the
basic mitochondrial bioenergetic phenomena and included much
of the mitochondrial biochemistry from a variety of species and
organs. Although the Yugi and Tomita model has been
successfully modified to predict the dynamic response of boxidation in the context of human disease [7], it does not
incorporate some details required to reproduce a few specific
bioenergetic regulatory features of interest herein. The Wu et al.
model [1] was chosen as the base model for this work due to its

Introduction
Motivation for Model Study
The simulation of mathematical models of mitochondrial
bioenergetics provides a powerful analytical alternative to performing numerous exhaustive experiments. Such models aid in the
interpretation of experimental data and facilitate experimental
design for elucidating the supporting biochemical and physical
processes. Current experimental techniques limit the ability to
resolve details of the mitochondrial bioenergetic processes in vivo.
Specifically, many different chemical species and events must be
simultaneously monitored to track the profusion of enzymatic
reactions involved in the tricarboxylic acid (TCA) cycle, boxidation, the electron transport system (ETS), ATP synthesis and
electrolyte dynamics. Currently, it is impossible to accurately and
simultaneously measure all of these enzymatic processes in vivo with
any degree of precision. Nevertheless, a plethora of experimental
data is available on mitochondrial bioenergetics that was collected
using a variety of techniques, experimental conditions, and tissue
sources. No existing experimental data set is complete that consists
of measurements of all of the supporting chemical species and
events; therefore, the correct interpretation of the available
experimental data in isolation or as a collective unit is difficult.
This requires careful consideration of all potential data-consistent
dynamics of the unobserved species and events. To aid in the
interpretation, a quantitative framework established via mathematical model development and parameter identification through
experiment simulation is commonly employed in a collective
PLoS Computational Biology | www.ploscompbiol.org
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sensitive dehydrogenases, as well as, several modified TCA cycle
related rate expressions; 2) a two-site model for the adenine
nucleotide transporter [13]; 3) the Na+/Ca2+ cycle including a
non-linear dependence on inner mitochondrial membrane potential difference, yinside - youtside, (Dy) for the calcium uniporter
(CaUNI) [14], magnesium inhibition kinetics for the CaUNI, and
the proton-regulation of the mitochondrial Na+/H+ exchanger
(mNHE); and 4) the K+-cycle including the mitochondrial ATPdependent K+ channel (mKATP), electrophoretic K+-leak and the
mitochondrial K+/H+ exchanger (mKHE) with the mitochondrial
matrix volume regulation dynamics hypothesized by Garlid [15].
Each addition is described in the following paragraphs.
The model proposed in the manuscript is a 73 state system of
differential-algebraic equations (DAEs) that consists of 65 nonlinear ordinary differential equations (ODEs); five algebraic
conservation expressions to compute matrix ATP, guanidine
triphosphate (GTP), reduced nicotinamide adenine dinucleotide
(NADH), ubiquinol (UQH2) and reduced cytochrome c (c2+); one
algebraic expression to compute matrix water volume; one
algebraic expression to compute inner membrane space (IMS)
water volume and one algebraic expression to compute matrix
chloride content (Cl2). The majority of the experimental data used
to parameterize the model proposed in this manuscript were
derived from heart tissue of either bovine, porcine or rat with some
data obtained from liver tissue. Part S1 of the Supplemental
Material (Text S1) lists the state variables and general parameters,
Part S2 contains the system of DAEs comprising the model and
Part S3 provides a detailed description of the rate expressions and
their parameters used to construct the system of DAEs. Part S3
also includes the fitness for some rate expressions calibrated with
additional experimental data not explicitly indicated in this
manuscript.
The TCA and related enzyme rate expressions are structurally
identical to Wu et al. except for a few alterations. To include the
calcium-dependence of matrix dehydrogenases, the rate expressions for pyruvate dehydrogenase (PDH), isocitrate dehydrogenase
(IDH) and a-ketoglutarate dehydrogenase (aKGDH) were modified. PDH, an important regulatory enzyme involved with
mitochondrial bioenergetics, is responsible for the oxidative
decarboxylation of pyruvate, transacylation of an acetyl group to
CoA and production of reducing equivalents for the ETS. A
similar rate expression found in Wu et al. was used with a few
notable modifications. The proton, divalent cation and adenine
nucleotide regulatory mechanisms were inserted into the expression to reproduce the available data [16]. IDH is responsible for
the oxidative decarboxylation of isocitrate to produce a-ketoglutarate and reducing equivalents for the ETS. The rate expression
used in the model is from Qi et al. [17]. The key TCA regulatory
enzyme, aKGDH, is responsible for the oxidative decarboxylation
of a-ketoglutarate transferring a succinyl group to CoA and
producing reducing equivalents for the ETS. The consensus hexauni-ping-pong mechanism with the appropriate activation and
inhibition modifications was used to reproduce a wide variety of
data from four independent data sets [18–21].
Two additional rate expressions that deviated from Wu et al. are
the glutamate-aspartate exchanger (GAE) and dicarboxylate
carrier (DCC). The GAE is a key enzyme in the malate-aspartate
shuttle and is particularly important maintaining state 3 NADH
levels when mitochondria respire on glutamate and malate. This
electrogenic exchanger is activated by calcium and swaps
glutamate and a proton with aspartate taking advantage of the
energized state of mitochondria established by the ETS. The
enzyme reaction was modeled based on a rapid equilibrium bi-bi
mechanism with a third substrate, protons, added to the rate

Author Summary
Mathematically modeling biological systems challenges
our current understanding of the physical and biochemical
events contributing to the observed dynamics. It requires
careful consideration of hypothesized mechanisms, model
development assumptions and details regarding the
experimental conditions. We have adopted a modeling
approach to translate these factors that explicitly considers
the thermodynamic constraints, biochemical states and
reaction mechanisms during model development. Such
models have numerous constant parameters that must be
determined. Integrating thermodynamics and detailed
mechanistic representation of the principal phenomena
help constrain these parameter values; therefore, only a
handful of the total number of model parameters (,10%)
must be adjusted during parameter estimation through
model simulations. Additionally, all models must undergo
some form of corroboration prior to application. In
practice, this corroboration should challenge all possible
dynamics of the model, but it is recognized that in this
data rich world, we are surprisingly data poor. Eventually
such developed and corroborated models are capable of
supporting current hypotheses, guiding experimental
designs and contributing to the overall knowledge base
of biological processes.
meticulous attention to thermodynamics and inclusion of the
various biochemical species present in the mitochondrial milieu.
Our model structure and the parameter values were selected so
that simulations of the experimental conditions on porcine or rat
heart mitochondria simultaneously fit the inorganic phosphate (Pi)
control over mitochondrial bioenergetics [8] and TCA intermediate dynamics [9] data sets upon which the Wu et al. model was
developed as well as additional experimental data on the extramitochondrial calcium-dependent steady state matrix calcium
concentrations [10] and mitochondrial matrix volume dynamics
[11]. Numerous other experimental studies were used to fit
constants for the employed rate expressions as described in the
Supplemental Material (Text S1). The resulting extended model is
corroborated with additional experimental data on the steady state
behavior of the TCA cycle [9], volume dynamics under various
bioenergetic/pharmacological interventions [11] and the bioenergetic/volume responses of mitochondria to variations in buffer
osmolarity [12]; a local sensitivity analysis was also used to explore
the robustness of the model structure relative to these simulated
experiments. This manuscript describes all phases of this process
including the model development, parameter estimation and
corroboration. It concludes with a discussion of the insights on the
bioenergetic processes obtained during the model extension.

Results
Model Development
The model integrates mitochondrial bioenergetic processes as
shown in Figure 1 including oxidative phosphorylation, the ETS,
the TCA cycle and related reactions, the Na+/Ca2+ cycle and the
K+-cycle. To maintain thermodynamic consistency, all reactions in
the model, as shown in Table 1, are represented as thermodynamically balanced and reversible. (It should be noted that some of
the reactions could have been treated as irreversible reactions since
the conditions necessary to reverse them lie very far from
physiological conditions.) The model is primarily based on the
mitochondrial bioenergetics model proposed by Wu et al. [1] and
extended to address: 1) updated formalisms for the calciumPLoS Computational Biology | www.ploscompbiol.org
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Figure 1. A graphical representation of the bioenergetic elements and processes described by the model. Abbreviations: Oxphos,
oxidative phosphorylation elements; PYR, pyruvate; CoASH, coenzyme A; AcCoA, acetyl-coenzyme A; CIT, citrate; ISOC, isocitrate; aKG, aketoglutarate; SCoA, succinyl CoA; SUC, succinate; FUM, fumarate; MAL, malate; OAA, oxaloacetate; GLU, glutamate; ASP, aspartate; NADH, reduced
nicotinamide adenine dinucleotide; NAD, GTP, guanidine triphosphate; GDP, guanidine diphosphate; oxidized nicotinamide adenine dinucleotide; Pi,
inorganic phosphate; UQ, ubiquinone; UQH2, ubiquinol; Cytc3+, oxidized cytochrome c; Cytc2+, reduced cytochrome c; PDH, pyruvate dehydrogenase;
CS, citrate synthase; ACH, acontinase; IDH, isocitrate dehydrogenase; aKGDH, a-ketoglutarate dehydroganse; SCoAS; succinyl CoA synthetase; SDH,
succinate dyhdrogenase; FH, fumarate hydratase; MDH, malate dehydrogenase; GOT, glutamate oxaloacetate transaminase; CI, Complex I; CIII,
Complex III; CIV, Complex IV; mHleak, proton leak; F1FO, F1FO ATP synthase; ANT, adenine nucleotide transporter; PIC, inorganic phosphate carrier;
GAE, glutamate/aspartate exchanger; OME, a-ketoglutarate/malate exchanger; DCC, dicarboxylate carrier; TCC, tricarboxylate carrier; PYRH, pyruvateproton cotransporter; GLUH, glutamate-proton cotransporter; mKATP, ATP-dependent K+ channel; mKHE, K+/H+ exchanger; mKleak, K+ leak; mNHE,
Na+/H+ exchanger; mNCE, Na+/Ca2+ exchanger; CaUNI, Ca2+ uniporter; AK, adenylate kinase.
doi:10.1371/journal.pcbi.1000632.g001

these issues and was therefore chosen to describe the ANT kinetics.
The parameters were refit to the original data to include the effect
of Na+ and K+ chelation of adenine nucleotides.
The model proposed in this manuscript incorporates mitochondrial calcium dynamics similar to Nguyen et al. [2], Cortassa et al.
[3] and Dash and Beard [14]. The CaUNI is similar to the
expression found in Dash and Beard including the nonlinear
dependence on Dy with the addition of explicit magnesium
inhibition based on experimental data. In Part S3 of the
Supplemental Material (Text S1), the magnesium inhibition was
used to show that a single calcium dissociation constant with
magnesium acting as a competitive inhibitor against calcium
binding for the channel is capable of reproducing the experimental
data (consisting of both rat heart and liver mitochondria). The

expression; it was fit to data from bovine heart mitochondria
[22–23]. The DCC exchanges TCA cycle intermediates malate,
succinate and hydrogen phosphate. This exchanger was also
modeled as forming a ternary complex with its substrates, and the
kinetic parameters were fit to rat liver mitochondrial experimental
data [24–25].
The ANT is the enzyme responsible for exchanging unchealated
ATP and ADP across the mitochondrial inner membrane.
Previous models used a ping-pong mechanism that employed a
single adenine nucleotide binding site whereby Dy affected only
ATP binding [26]. This type of mechanism has been shown to
inadequately describe the enzyme kinetics, and studies have
identified at least two distinct adenine nucleotide binding sites
[27–28]. The model presented by Metelkin et al. [13] addresses
PLoS Computational Biology | www.ploscompbiol.org
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Table 1. Modeled Mitochondrial Bioenergetic Reactions.

Reaction

Enzyme

Biochemical Reaction

Mitochondrial Reactions
JPDH

Pyruvate dehydrogenase

PYR + CoASH + NAD + H2O « CO2 + SCOA + NADH

JCS

Citrate synthase

OAA + AcCoA + H2O « CoASH + CIT

JACH

Aconitase

CIT « ISOC

JIDH

Isocitrate dehydrogenase

NAD + ISOC + H2O « aKG + NADH + CO2

JaKGDH

a-Ketoglutarate dehydrogenase

aKG + CoASH + NAD + H2O « CO2 + SCoA + NADH

JSCoAS

Succinyl CoA synthase

SCoA + GDP + Pi « SUC + GTP + CoASH

JSDH

Succinate dehydrogenase

SUC + UQ « UQH2 + FUM

JFH

Fumarate hydratase

FUM + H2O « MAL

JMDH

Malate dehydrogenase

NAD + MAL « OAA + NADH

JNDK

Nucleoside diphosphokinase

GTP + ADP « GDP + ATP

JGOT

Glutamate oxaloacetate transaminase

ASP + aKG « OAA + GLU

JCI

Complex I

NADH + UQ « NAD + UQH2

JCIII

Complex III

UQH2 + 2Cytc3+ « UQ + 2Cytc2+

JCIV

Complex IV

2Cytcred + KO2 « 2Cytcox + H2O

JF1FO

F1FO ATP synthase

ADP + Pi « ATP + H2O

JAK

Adenylate Kinase

2ADP « ATP + AMP

JGAE

Glutamate-aspartate exchanger

JOME

a-Ketoglutarate-malate exchanger

aKGims + MALmtx « aKGmtx + MALims

JPYRH

Pyruvate-proton cotransporter

PYRims + H+ims « PYRmtx + H+mtx

JGLUH

Glutamate-proton cotransporter

GLUims + H+ims « GLUmtx + H+mtx

JCITMAL

Tricarboxylate carrier

CITims + MALmtx « CITmtx + MALims

JISCOMAL

Tricarboxylate carrier

ISOCims + MALmtx « ISOCmtx + MALims

JSUCPi

Dicarboxylate carrier

SUCmtx + Piims « SU Cims + Pimtx

JMALPi

Dicarboxylate carrier

MALmtx + Piims « MALims + Pimtx

JANT

Adenine nucleotide transporter

ATPmtx + ADPims « ATPims + ADPmtx

JPIC

Inorganic phosphate carrier

Piims + H+ims « Pimtx + H+mtx

JmHleak

Proton leak

H+ims « H+mtx

JmKHE

Potassium-hydrogen exchanger

H+ims + K+mtx « K+ims + H+mtx

JmKATP

ATP-dependent potassium channel

K+ims « K+mtx

JmKleak

Potassium leak

K+ims « K+mtx

JCaUNI

Calcium uniporter

Ca2+ims « Ca2+mtx

JmNCE

Sodium-calcium exchanger

Ca2+mtx + 3Na+ims « Ca2+ims + 3Na+mtx

JmNHE

Sodium-hydrogen exchanger

Na+mtx + H+ims « Na+ims + H+mtx

Exchangers and Ion Channels
GLUims + H+ims + ASPmtx « GLUmtx + H+mtx + ASPims

Other Reactions Used in the Model
JHK

Hexokinasea

GLC + ATP « G6P + ADP

abbrev: mtx, matrix; ims, intermembrane space.
Reaction is not presented in Figure 1.
doi:10.1371/journal.pcbi.1000632.t001
a

electrophoretically driven potassium uptake via leak pathways
must be balanced with potassium efflux from the mKHE.
Originally, the mKHE was thought to be regulated by the carrier
brake hypothesis [35]. This essentially involves some endogenous
element in the matrix, such as magnesium, that serves as the
‘‘carrier brake’’ that is reversibly released by matrix swelling.
Brierley and Jung call into question this hypothesis noting that
under physiological conditions, the known inhibitors of the
exchanger are present at concentrations much greater than their
respective inhibitory constants [36]. Garlid then proposed that the
mKHE is additionally regulated by matrix volume with membrane

mNCE is similar to [2–3,14] with the noted addition of a
hypothetical matrix calcium activation mechanism. This calcium
activation mechanism resulted in comparable dynamics under the
calcium loading experiments used to fit Dash and Beard’s matrix
calcium inhibition mechanism for the CaUNI but was extended to
be analogous with the current experimental evidence regarding
the sarcolemmal isoform [29]. The mNHE was slightly modified
from Nguyen et al. to include a hill coefficient of 2 for the proton
regulation mechanism.
The ‘futile’ K+-cycle plays a major role in mitochondrial volume
homeostasis [30–34]. Potassium influx via the mKATP and
PLoS Computational Biology | www.ploscompbiol.org
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aspartate and glutamate dynamics using pyruvate energized
mitochondria under both state 2 and state 3 respiratory conditions
were also consistent with experimental data. In these simulations,
the endogenous matrix aspartate content provided sufficient
amino acid substrates for glutamate oxaloacetate transaminase
(GOT) while glutamate efflux via glutamate-H+ cotransporter
reduced the total available matrix asparate/glutamate pool.
The Na+/Ca2+ cycle was fitted to the steady state data from
Wan et al. [10]. In their experiments, they used ATP-energized
mitochondria and monitored steady state Ca2+ levels at varying
extra-mitochondrial Ca2+, Na+ and Mg2+ concentrations. The
ATP initialized the mitochondrial Dy to approximately 2120 mV
in the model simulations corroborating the data reported by
Territo et al. [37]. The model’s capability of fitting the extramitochondrial Ca2+- and Na+-dependence on matrix steady state
Ca2+ concentrations is illustrated in Figure 5. The steady sate
matrix free Ca2+ data in the absence of extra-mitochondrial Na+ is
not shown nor was used in the parameter estimation, because the
Na+-independent calcium efflux was not included in the model
structure. (Note, with an electroneutral Ca2+/2H+ exchange
mechanism, the Na+-independent steady state matrix Ca2+ data
could be reproduced by the model; however, this mechanism was
not included in the current model formulation. The rationale for
this choice is described in more detail in the Discussion.)
The volume dynamics were fitted to the transient mitochondrial
matrix swelling data published by Kowalowski et al. [11]. They
measured the effect of varying matrix ATP levels on the swelling
dynamics in K-salt media with succinate-energized mitochondria.
Figure 6 shows that the volume dynamics were captured well by
the model. When a small amount of ATP was included in the
buffer in the presence of oligomycin, a F1FO ATP synthase
inhibitor, the mitochondria swelled to approximately 1.5 mL/mg
in about four minutes. When the ATP was supplemented with
ADP, oxidative phosphorylation was activated which lowered the
Dy and generated matrix ATP. This reduced the electrophoretic
potassium uptake and inhibited the mKATP channel, respectively,
so that the steady state volume reached a lower value of
approximately 1.2 mL/mg. When ATP was not present, all
residual matrix ATP was converted to ADP via reverse activation
of the F1FO ATP synthase. This fully activated the mKATP
channel, so that the final steady state volume reached a much
higher value of about 2.0 mL/mg.

stretching activating the exchanger [15]. Further evidence for this
mechanism is provided by the results of the analysis of the
mathematical model proposed in this manuscript discussed below.

Parameter Estimation
To parameterize the model, four independent data sets
consisting of 32 data curves were used from Bose et al. [8],
LaNoue et al. [9], Wan et al. [10] and Kowaltowski et al. [11]. In
the manuscript these studies will be henceforth referenced as the
Bose data set, LaNoue data set, Wan data set and Kowaltowski
data set, respectively. For each data set, the model was initialized
from a condensed, fully oxidized and de-energized state via
initialization simulations that replicated the experimental incubation conditions (i.e. Pi- and Ca2+-depletion) prior to parameter
estimation. The parameter identification was subsequently conducted using simulation conditions closely mimicking those
of the experimental methods. The resulting values of the 42
adjustable parameters, their definitions, their best fit values and
their associated normalized local sensitivity coefficients (LSC) are
provided in Table 2. The following paragraphs describe the ability
of the model with these fitted parameter values to reproduce the
experimental results from these four independent experimental
data sets; pertinent details of the experimental conditions and their
replication through model simulations are described in the
Methods section.
The NADH-linked respiration components of the model were
fitted against the Pi-titration experiments performed by Bose et al.
[8]. In their manuscript, the authors reported a rich bioenergetic
data set using glutamate/malate energized, Pi-depleted mitochondria under both state 2 and state 3 respiration conditions. State 3
was initiated and maintained with a sufficient bolus addition of
1.3 mM ADP. At this concentration, maximum respiration was
maintained for at least half a minute before the ANT exerted its
control due to limited substrate availability. Mitochondrial Dy,
NAD/NADH redox state, myocardial oxygen consumption
(MVO2), cytochrome c3+/c2+ redox state and matrix pH were
reported as the extra-mitochondrial Pi was progressively increased
from 0 to 10 mM. Figure 2 shows that the model was capable of
fitting this data set. Similar to the Wu et al. model, the model
presented in this manuscript produced state 3 Dy that reproduced
the Pi-titration trend but at 10–15 mV lower than the experimentally measured state 3 Dy. To achieve the low matrix pH
levels observed experimentally, the mKHE was temporarily
replaced with an expression with sufficient activity to rapidly
equilibrate [K+]mtx[H+]ims/[K+]ims/[H+]mtx, and the initial matrix
[K+] was adjusted to approximately 125 mM. Without these
modifications for this data set, the model produced matrix pH of
up to 7.2–7.5 pH units under the experimental conditions
simulated. This issue is further explored in the Discussion. Overall,
the experimentally reported Dy, NAD/NADH redox state and
MVO2 Pi-titrations as well as the expected increase in volume with
increasing Pi are captured by the model.
The TCA cycle intermediate dynamics of the model were fitted
to the data set presented by LaNoue et al. [9]. In their
experiments, they used pyruvate/malate and pyruvate energized
mitochondria in both state 2 and state 3 respiration. State 3 was
initiated by the addition of 0.5 mM ADP and maintained using a
hexokinase trap. They reported detailed time series data of most of
the TCA cycle intermediates for each experimental condition. The
model was able to capture the salient features of the pyruvate/
malate energized mitochondrial TCA cycle intermediate dynamics
as shown in Figure 3. The model simulated pyruvate, citrate,
isocitrate, a-ketoglutarate, succinate and malate transients similar
to the experimental data. Figure 4 shows that the simulated
PLoS Computational Biology | www.ploscompbiol.org

Corroborating the Model through Simulation
Model corroboration was necessary to establish confidence in
the model resulting from these efforts. Herein, the corroboration
considered the robustness of the model to local parameter
perturbations, the qualitative agreement of predicted trends with
experimental observations, and the ability of the model to
reproduce experimental data that was not used in fitting its
parameters.
A local sensitivity analysis on the model was performed to
determine how robust the model simulations were to local
perturbations in the parameter values of all the experiments used
in the parameter identification. The absolute-value normalized
local sensitivity coefficients (LSC) were computed using Equation 2
as defined in the Methods section which considered variations for
every state variable dynamics uniformly throughout the simulated
experiment duration. The average LSC of all 359 parameters was
only 7.3861023 with a variance of 1.1861023. This implies on
average that a perturbation of 1% for a given parameter results in
less than a 0.738 +/2 0.118% change in the state dynamics of the
model for the experiments considered. Of the 42 adjustable
parameters, the average of the absolute-value normalized LSC
5
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Table 2. Description of Adjustable Parameters (T = 25uC).

Parameter

Definition

Value (LSCx100)

Units

PDH
Vmax

Pyruvate dehydrogenase max rate

127 (4.88)

nmol/min/mg

CS
Vmax

Citrate synthase max rate

584 (1.64)

nmol/min/mg

ACH
Vmf

Acontinase max forward rate

1.166105 (0.011)

nmol/min/mg

4

IDH
Vmax

Isocitrate dehydrogenase max rate

6.84610 (0.341)

nmol/min/mg

aKGDH
Vmax

a-Ketoglutarate dehydrogenase max rate

779 (2.18)

nmol/min/mg

SCoAS
Vmf

Succinyl CoA synthase max forward rate

3.936104 (0.216)

nmol/min/mg

SDH
Vmf

Succinate dehydrogenase max forward rate

7.006103 (2.26)

nmol/min/mg

FH
Vmf

Fumurate hydratase max forward rate

7.676105 (0.010)

nmol/min/mg

MDH
Vmf

Malate dehydrogenase max forward rate

965 (0.432)

nmol/min/mg

MDH
KPi

Malate dehydrogenase Pi binding constant

5.0061023 (0.156)

M

bMDH
Pi

Malate dehydrogenase Pi activation constant

57.7 (0.193)

unitless

NDK
Vmf

Nucleoside diphosphokinase max forward rate

6.956103 (0.016)

nmol/min/mg

GOT
Vmf

Glutamate oxaloacetate transaminase max forward rate

1.096106 (0.251)

nmol/min/mg

PYRH
Vmax

Pyruvate-hydrogen co-transporter activity

3.12610

13

(0.651)

nmol/M2/min/mg

10

(0.763)

nmol/M2/min/mg

GLUH
Vmax

Glutamate-hydrogen co-transporter activity

9.44610

TCC
Vmax

Tricarboxylate activity

7.136108 (0.471)
3

nmol/M2/min/mg

OME
Vmax

a-Ketoglutarate-malate exchanger max forward rate

8.83610 (0.275)

nmol/min/mg

VoGAE

Glutamate-aspartate exchanger un-stimulated max rate

674 (0.865)

nmol/min/mg

bGAE
Ca

Glutamate-aspartate calcium activation constant

27.2 (0.299)

unitless

DCC
Vmax

Dicarboxylate carrier max rate

8.036103 (0.901)

nmol/min/mg

VCI

Complex I activity

5.636106 (0.962)

nmol/M2/min/mg

VCIII

Complex III activity

5.846105 (2.19)

nmol/M3/2/ming/mg

CIII
KPi

Complex III Pi binding constant

4.4061023 (0.976)

M

bCIII
Pi

Complex III Pi activation constant

148 (1.54)

unitless

VCIV

Complex IV activity

44.0 (2.19)

nmol/M/min/mg

7

F1 FO
Vmf

F1FO ATP synthase activity

1.91610 (0.027)

nmol/M/min/mg

ANT
Vmf

Adenine nucleotide translocase max rate

365 (7.52)

nmol/min/mg

PIC
Vmax

Inorganic phosphate carrier max rate

7.596107 (0.012)

nmol/min/mg

PmHleak
H

Proton permeability

8.066107 (5.01)

nmol/M/min/mg

mKHE
Vmax

Potassium-hydrogen exchanger max rate

6.25 (3.58)

nmol/nl/min/mg

GKmKATP

ATP-dependent potassium channel conductance

6.75 (0.181)

nmol/min/mg

mKATP
KiMgATP

ATP-dependent potassium channel MgATP inhibition constant

4.1061029 (0.061)

M

mKATP
KiMgADP

ATP-dependent potassium channel MgADP inhibition constant

10.0610

26

PmKleak
K

Potassium permeability

13.8 (4.87)

nmol/M/min/mg

PCaUNI
Ca

Calcium uniporter calcium permeability

157 (0.403)

nmol/min/mg

mNCE
Vmax

Sodium-calcium exchanger max rate

0.731 (0.360)

nmol/min/mg

mNCE
KCa

Sodium-calcium exchanger calcium binding constant

4.1761026 (0.326)

M

mNCE
KNa

Sodium-calcium exchanger sodium binding constant

1.72610

23

M

mNCE
KaCa

Sodium-calcium exchanger calcium activation binding constant

1.6661026 (0.238)

M

bmNCE
Ca

Sodium-calcium exchanger calcium activation constant

67.6 (0.296)

unitless

mNHE
Vmax

Sodium-hydrogen exchanger max rate

9.456105 (0.061)

nmol/min/mg

HK
Vmax

Hexokinase max rate

1.206105 (5.14)

nmol/min/mg

(0.063)

(0.018)

M

abbrev: LSC, local sensitivity coefficient (Note, the LSC is an average of the absolute value 1st order sensitivity of a parameter with respect to all state variables, time
points and experimental conditions used in this study. It is explicitly defined in Equation 2. In brief, a d change in a given parameter translates to a dLSC change in the
model output defined in the Sensitivity Analysis section of the Methods.).
doi:10.1371/journal.pcbi.1000632.t002
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Figure 2. Model simulations (lines) of the Pi control exerted over mitochondrial bioenergetics shown in comparison with isolated
mitochondria experimental data (symbols) for the conditions outlined in Bose et al. [8]. Mitochondria were incubated in the assay buffer
identified in the Methods section under the Bose data set description. State 2 simulation results and experimental data are shown as solid lines and circles,
respectively. State 3 simulations results and experimental data are shown as dotted lines and squares, respectively. The simulated Pi-titration response is
shown with the experimentally measured data for the A) MVO2, B) redox state (percent NADH), C) Dy, D) reduced cytochrome c (percent c2+), E) matrix pH
and F) the simulated matrix volume.
doi:10.1371/journal.pcbi.1000632.g002

Figure 3. Model simulations (lines) of pyruvate/malate supported respiration on the levels of various TCA cycle intermediates
compared with isolated mitochondria experimental data (symbols) for the conditions outlined in LaNoue et al. [9]. Mitochondria were
incubated in the assay buffer identified in the Methods section under the LaNoue data set description. State 2 simulation results and experimental
data are shown as solid lines and circles, respectively. State 3 simulations results and experimental data are shown as dotted lines and squares,
respectively. The simulated TCA intermediate dynamics is shown with the experimentally measured data for A) the pyruvate utilization, B) the
accumulation of lumped citrate and isocitrate, C) the accumulation of extra-mitochondrial lumped citrate and isocitrate, D) the accumulation of
a-ketoglutarate, E) the accumulation of succinate and F) the residual malate content.
doi:10.1371/journal.pcbi.1000632.g003
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Figure 5. Model simulations (lines) of the steady state matrix
free calcium relationship with respect to varying extramitochondrial calcium levels in comparison with isolated
mitochondria experimental data (symbols) for the conditions
outlined in Wan et al. [10]. Mitochondria were incubated in the assay
buffer identified in the Methods section under the Wan data set
description. The steady state matrix free calcium concentration is
shown versus varying extra-mitochondrial calcium in the presence of 2
(solid line, circles), 5 (dashed, squares) and 20 (dotted line, diamonds)
mM NaCl with 5 mM MgCl2.
doi:10.1371/journal.pcbi.1000632.g005

and exchanged with the malate in the media via the oxoglutaratemalate exchanger. This exchanger is a critical component of the
malate-aspartate shuttle and is particularly important in heart
tissue.

Figure 4. Model simulations (lines) of pyruvate supported
respiration on the levels of the amino acids aspartate and
glutamate in comparison with isolated mitochondria experimental data (symbols) for the conditions outlined in LaNoue et
al. [9]. Mitochondria were incubated in the assay buffer identified in
the Methods section under the LaNoue data set description. The
simulated accumulation of aspartate (solid line) and glutamate (dotted
line) are shown with experimentally measured aspartate (circles) and
glutamate (squares). A) State 2, B) State 3.
doi:10.1371/journal.pcbi.1000632.g004

reported in Table 2 was 1.2661023 with a variance of 3.2361024.
These low sensitivities for the model parameter values did not
reveal any inherent problems with the model structure.
The model was also able to reproduce the well known
mitochondrial shrinkage/swelling dynamics in the presence of Pi
and ADP. Figure 2F shows that as the extra-mitochondrial Pititration was increased, mitochondrial matrix water volume
increased with the state 3 volume being lower than the state 2
volume. Unfortunately, no volume data for the Bose data set was
given; however, the model results do corroborate the qualitative
observations presented therein with volume increasing for higher
amounts of Pi in the medium.
The model was directly corroborated by predicting the steady
state accumulation of extra-mitochondrial a-ketoglutarate during
state 2 respiration at various extra-mitochondrial malate concentrations as shown in Figure 7. As the extra-mitochondrial malate
concentration was increased, the total amount of a-ketoglutarate
generated from the oxidation of pyruvate was also increased
PLoS Computational Biology | www.ploscompbiol.org

Figure 6. Model simulations (lines) of the matrix volume
dynamics under various altered states of the mitochondrial
bioenergetics shown in comparison with isolated mitochondria experimental data (symbols) for the conditions outlined in
Kowaltowski et al. [11]. Mitochondria were incubated in the assay
buffer identified in the Methods section under the Kowaltowski data set
description. A small amount of ATP, 200 mM, was included in the assay
buffer with either 0.5 mg/mg oligomycin (solid line, circles), 1 mM ADP
(dashed line, squares) or 0.5 mg/mg oligomycin+1 mM ADP (dotted line,
diamonds). In a separate experiment, no ATP was included in the assay
buffer with 0.5 mg/ml oligomycin (dash-dot line, triangles).
doi:10.1371/journal.pcbi.1000632.g006
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Figure 7. Model predictions (line) of the steady state extramitochondrial a-ketoglutarate concentrations during state 2
respiration with various extra-mitochondrial malate concentrations (symbols) is compared to the experimentally reported
values outlined in LaNoue et al. [9]. Mitochondria were incubated
in the assay buffer identified in the Methods section under the LaNoue
data set description. Extra-mitochondrial malate was incrementally
increased from 0 to 5 mM in the presence of 2 mM pyruvate. The
model was simulated at sufficient times to achieve a-ketoglutarate
steady state concentrations.
doi:10.1371/journal.pcbi.1000632.g007

The model was again directly corroborated by predicting the
experimentally observed mitochondrial volume dynamics after
various bioenergetic and/or mKATP interventions. Figure 8
shows that when the mKATP channel was manipulated via
normal or pharmacological pathways, the model was capable of
predicting the matrix volume changes observed. This highlights
the interactions between K+-influx via mKATP and mKleak and
K+-efflux via mKHE and identifies their role in mitochondrial
volume regulation. Upon energization, electrophoretic uptake of
K-salts increased matrix volume in an osmotic fashion. The first
principles representation of mitochondrial volume dynamics was
captured well by the model.
Finally, the model’s ability to reproduce the expected trends in
bioenergetic variables under varying KCl buffer osmolarity
conditions was explored. Devin et al. [12] monitored changes in
state 2 and state 3 Dy, matrix pH, proton motive force, MVO2,
NADH level and matrix volume as the buffer osmolarity was
changed from a hypoosmolar to a hyperosmolar KCl medium
using rat liver mitochondria. Although the model presented in this
manuscript was optimized to reproduce experimental data
primarily from heart tissue, the effect of varying medium
osmolarities on key bioenergetic variables was qualitatively
reproduced. Only a partial quantitative comparison to this data
was possible due to tissue source differences, experimental
limitations, and model structure (as further described in the
Discussion). Figure 9A shows that the simulated state 2 MVO2
matched the experimental trend; however, the model simulated
the incorrect trend for state 3 MVO2. This is attributed to the
tissue source and model structure detailed below in the Discussion.
The simulated Dy trends matched the reported experimental
trends (state 2: 2140 to 2160 mV and state 3: 2125 to
2135 mV) as shown in Figure 9B. Also, the simulated DpH
(pHmtx-pHims) trends matched the reported experimental trends
(state 2: 230 to 245 mV and state 3: 235 to 250 mV) as shown
PLoS Computational Biology | www.ploscompbiol.org

Figure 8. Model predictions (lines) of mitochondrial volume in
comparison with isolated mitochondria experimental data
(symbols) for the conditions outlined in Kowaltowski et al.
[11]. Mitochondria were incubated in the assay buffer identified in the
Methods section under the Kowaltowski data set description. A) In each
case, 200 mM ATP was included in the assay buffer. Volume dynamics
were then measured with either 1 mM ADP and 30 mM diazoxide (solid
line, circles) or 1 mM ADP, 30 mM diazoxide and 300 mM 5-hydroxydecanoate (dashed line, sqaures) added to the assay buffer. B) In each
case, 0.5 ug/ml oligomycin was included in the assay buffer. Volume
dynamics were then measured with either 200 mM ATP (dashed line,
circles); 200 mM ATP and 30 mM diazoxide (solid line, square) or 200 mM
ATP, 30 mM diazoxide and 300 mM 5-hydroxydecanoate (dash-dot line,
diamond) added to the assay buffer (note, the dash-dot line is hidden
by the solid line).
doi:10.1371/journal.pcbi.1000632.g008

in Figure 9C. Although the simulated Dys and the DpHs are overand underestimated, respectively, the proton motive force (Dy +
2.303RT/F DpH) matched the experimental data very well as
shown in Figure 9D. In other words, as the medium osmolarity
varied the total thermodynamic driving force established by the
ETS was very similar to that observed experimentally. Devin et al.
observed that from hypoosmotic conditions, the NADH levels
increased and leveled off as the buffer osmolarity was increased
towards hyperosmotic conditions. As shown in Figure 9E, the
model was able to reproduce this trend very well. They also
reported that in hyperosmotic KCl medium, mitochondrial matrix
volume is efficiently regulated, such that the steady state volume is
essentially retained, but in hyposomotic KCl medium, the matrix
volume dramatically increases relative to isoosomotic conditions
9
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Figure 9. Model predictions (lines) of mitochondrial bioenergetic parameters under differing osmotic KCl medium with isolated
mitochondria experimental data (symbols) for the conditions outlined in Devin et al. [12]. Mitochondria were incubated in the assay
buffer identified in the Methods section under the Devin data set description. As the osmotic pressure of the KCl medium was adjusted from
hypoosmotic to hyperosmotic conditions, A) MVO2, B) Dy, C) DpH (defined as pHmtx-pHcyt), D) proton motive force (Dy+2.303RT/FDpH), E) %NADH
level and F) matrix volume predicted by the model is presented.
doi:10.1371/journal.pcbi.1000632.g009

[12]. Figure 9F shows that the model volume mechanics
adequately reproduced this phenomenon. Overall, the model
corroborated the trends of the changes in bioenergetic variables as
buffer osmolarity varies.

occurs in vivo during ischemia. This contraction interferes with the
regulation of the adenine nucleotide outer membrane permeability, thereby enabling mitochondria to burn up all the cells
available ATP and primes the cell for apoptosis before reperfusion.
As a natural defense, potassium influx via mKATP increases
matrix volume and helps mitigate the detrimental effects of
increased adenine nucleotide outer membrane permeability [38].
As a first step to consider these important volume regulatory
events, the model incorporates simple volume dynamics based on
osmotic pressures generated by the K+-cycle and other associated
processes. Future work studying this intricate energy transduction
mechanism is in the beginning stages of development.
The hypothesized volume-dependent mKHE by Garid [15] was
incorporated into the model. This volume dependence is necessary
to maintain sufficient potassium efflux at high Dy during mKATP
opening. Without this dependence, the mKHE would be an
ineffective volume regulatory mechanism, and the outer membrane would rupture. Specifically, potassium influx induced upon
mKATP opening is maintained and essentially constant at a given
Dy because the current cannot sufficiently depolarize the Dy and
because of thermodynamic considerations [33]. Also, model
simulations revealed that matrix free Mg2+ only decreased from
0.4 mM to approximately 0.15 mM (depending on total amount
of Mg-ligands, such as ATP and Pi, present in the matrix and the
matrix volume) under the experimental conditions. This decrease
is insufficient to serve as the primary volume controller required by
the carrier-brake hypothesis. These observations require that
mKHE posses some sort of volume dependence enabling an
effective volume controlling mechanism. This hypothesis was
supported by simulation results presented in Figures 6, 8 and 9F
whereby the exquisite control of matrix volume exhibited by
mKHE was revealed.

Discussion
The model presented in this manuscript is based on previous
models [1–4] and includes integrated calcium dynamics and a
detailed description of the K+-cycle and its effect on mitochondrial
bioenergetics and matrix volume regulation. Simulations were
used to fit 42 adjustable parameters to four independent
experimental data sets consisting of 32 data curves of both
transient and steady state data. A sensitivity analysis was
performed on the model to reveal the most sensitive components
of mitochondrial bioenergetics relative to the experimental
conditions modeled herein and revealed no inherent model
structural problems. Finally, several simulations were performed
to corroborate the model.
The mitochondrial volume dynamics and the associated K+cycle appear to play an important role in cellular and
mitochondrial bioenergetics [15,38]. Energy transduction, namely
adenine nucleotide outer membrane permeability, is regulated
under both physiological and pathophysiological conditions [39].
The IMS volume is partly responsible for this regulation by having
a direct effect on the cellular bioenergetics in vivo [38]. For
example, the adenine nucleotide outer membrane permeability is
typically high in freshly isolated mitochondria due to matrix
contraction following potassium depletion. During mitochondrial
swelling, the increase in matrix volume causes a reciprocal
decrease in IMS volume that enables creatine kinase to bind to
the voltage-dependent anion channel thus reducing the adenine
nucleotide outer membrane permeability. Matrix contraction also
PLoS Computational Biology | www.ploscompbiol.org
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LaNoue data set. As further indirect support for the proposed
elevated glutamate-H cotransporter activity, increased glutamate
influx helps enable state 2 and state 3 respiration on glutamate and
malate for the Bose data set simulations as shown in Figure 2. At
this point, neither mechanism has been proven experimentally.
Another exchanger reported to possess low activity in heart
tissue is the dicarboxylate carrier [43]. This carrier is responsible
for the exchange of primarily Pi, malate and succinate. However,
without sufficiently high activity, the succinate-energized mitochondrial matrix volume data reported by Kowaltowski et al. [11]
could not be reproduced by the model. Elevated DCC rates were
necessary to provide sufficient succinate influx allowing electrophoretic potassium uptake. If the DCC activity was limited to the
reported maximum rate [44], the mitochondrial Dy would not
polarize substantially and mitigate the reported potassiumdependent volume increase.
The chosen substrates for the DCC also affected the model
simulation capabilities. In the model formulation, only Pi, malate
and succinate were assigned as the DCC substrates. Fumarate is
also reported to be a substrate for the DCC [45] but was not
included in the model due to insufficient data to characterize the
kinetics. Including fumarate in the list of the DCC substrates
would enable to the model to reproduce the accumulated fumarate
data from LaNoue data set (not shown). Also, the omission of
fumarate as a substrate for the DCC in addition to the DCC
elevated activity contributed to the simulated state 3 malate net
oxidation present in Figure 3F.
An additional tissue source related phenomena uncovered
during model development was the choice of the calcium
dissociation constant for the CaUNI. During model development,
a single calcium dissociation constant was chosen to model the
CaUNI kinetics from rat heart and liver tissue. This was achieved
by considering the competitive nature of magnesium inhibition
with respect to calcium binding. It is plausible that the major
difference between liver and heart CaUNI kinetics is due to
different expression levels versus different calcium binding
affinities (as may be plausible between different species); however,
more research concerning this matter needs to be done.
Mitochondria from specific tissue types are phenotypically
different and contain various amounts of electron transport
proteins, matrix proteins and lipid types optimized to support
their designated function. Specifically, heart mitochondria possess
much higher electron transport activity relative to liver mitochondria [46]. Therefore, we partially attribute the discrepancies
between the simulated and reported values for the MVO2, Dy and
DpH, and under varying KCl buffer osmolarity conditions to
differences in the tissue source. The experiments outlined in Devin
et al. [12] were done using mitochondria isolated from rat liver
while the model was primarily developed to fit data obtained
from heart tissue. This is exemplified in Figure 9A–C. The model
simulated much higher state 3 MVO2 rates (200 versus
100 nmolO/min/mg); however, the state 2 MVO2 trends
(quantitative data not given) matched those reported. The
measured liver mitochondria Dys were several 10 s of mVs lower
relative to simulated Dys and is also partially attributed to the
model’s overestimation of state 3 Dy seen in Figure 2C. Although
the Dy and DpH energetic variables were quantitatively different,
it is interesting to note that the thermodynamic variable (proton
motive force) was consistent across the tissue types as would be
expected. Moreover, the authors suggested that the measured
hypoosmolar Dy may have been in error due to volume
dependent rhodamine 123 accumulation. This accumulation
may partially account for the discrepancy between the measured
hypoosmotic state 2 proton motive and that simulated. Thus the

To faithfully reproduce all the data sets, a certain network
topology had to be in place and some assumptions about uncertain
or unobserved experimental factors and conditions were explicitly
constrained. It was found that these network features and
experimental assumptions described below were necessary to
successfully recreate all the experimentally observed data and
trends. The necessity of these realizations contributes to our
collective understanding of the mitochondrial bioenergetics.
The intrinsic thermodynamic dissipation of a system can
override or mitigate enzymatic regulation [40]. For example, in
glutamate/malate energized mitochondria, aKGDH serves as a
key regulatory enzyme responsible for maintaining sufficient
NADH levels sustaining MVO2 rates in state 2 and state 3. This
reaction is far from equilibrium making it sensitive to its regulatory
mechanisms. In contrast, malate dehydrogenase (MDH) is much
closer to equilibrium so its regulatory mechanism less effectively
controls the dehydrogenase rate. In state 2, aKGDH is a major
enzyme in the pathway responsible for regenerating the matrix
ATP that is consumed by the F1FO ATP synthase to help the ETS
establish a high Dy. In state 3, this enzyme’s activity helps dictate
which path the carbon substrates flow through the TCA cycle.
The regulation for this enzyme helps enable mitochondria to
achieve the steady state NADH levels observed with the Bose Pititration data seen in Figure 2B. The relative rates identified from
the model simulations (not shown) predicted that the regulation of
MDH played less of a role in the steady state NADH Pi-dependent
levels than the regulation of aKGDH.
Animal model species specific parameterization may be
required for detailed mathematical models of the mitochondrial
bioenergetics; however, at this time there is not sufficient data
from a single species to fully characterize the dynamics. For
example, all the kinetic parameters for the aKGDH expression
were found using independent data sets obtained from porcine
heart mitochondria as described in Part S3 of the Supplemental
aKGDH
, the maximum rate
Material (Text S1) [18–21]. Only Vmax
constant, was refit with the fully integrated model simulations that
used data from both porcine and rat heart mitochondria. Future
compensation for the species specific enzyme kinetic differences
between these two isozymes may further improve the fit of the
simulated a-ketoglutarate dynamics to the experimental data in
Figure 3D.
The tissue type used for the supporting experiments is also
important for parameterization of a semi-mechanistic mathematical model. For example, in the model, several exchangers and
cotransporters are reported to possess low activity in heart tissue
compared with other tissues [41]. Although the definition for low
activity was ambiguous; herein to reproduce the experimental
data, it was necessary that some of these processes possess
unexpectedly elevated activities. For example without sufficiently
active glutamate-H cotransport, the model was unable to
reproduce the observed aspartate/glutamate dynamics reported
by LaNoue et al. [9] in Figure 4. The glutamate-H cotransporter is
responsible for the electroneutral transport of the amino acid
glutamate and a proton through the inner-mitochondrial membrane down a concentration gradient. This provides a glutamate
leak pathway that reduces the matrix aspartate/glutamate pool.
Reducing aspartate availability in the matrix prevents the
thermodynamically favorable reaction catalyzed by GOT from
consuming all of the endogenous aspartate. Alternatively to the
proposed elevation in the activity of the cotransporter, it has been
argued that there may be two separate aspartate pools [42] in
mitochondria. Compartmentalizing the total aspartate pool with
slow or volume-dependent transport rates would also enable the
model to reproduce the aspartate/glutamate dynamics in the
PLoS Computational Biology | www.ploscompbiol.org
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sodium concentrations shown in Figure 5 indicate this is not the
case. Alternatively, the differences between porcine and rat heart
mitochondria may be responsible for the dramatic change in
proton permeability. The Bose data set was obtained using porcine
heart mitochondria, while rat heart mitochondria were used for all
the other datasets. It is not likely that the proton permeability
associated with these two species is significantly different.
Conversely, the volume-dependent mKHE expression may not
sufficiently capture the phenomena. The model fits and corroboration simulations presented in Figure 6 and Figure 8, respectively, refute this conclusion. From this discussion, it is evident that
more experimental data measuring DpH and Dy under various
conditions is needed to reduce this uncertainty.
To simulate the precise experimental conditions during model
development, a few explicit assumptions were necessary. For
example, the LaNoue data set reported using 3–4 mg of
mitochondrial protein; however, as little as a 25% change in
mitochondrial load can dramatically alter the total substrate
consumption and product accumulation during high MVO2 rates.
Hence for these simulations, the conditions needed to be known
with more certainty. The reported malate concentration was used
to estimate the mitochondrial load. The initial malate content in
state 2 and state 3 experiments with pyruvate was reported to be
1430 nmol/mg. This required that the mitochondrial load be
3.5 mg/mL using the stated 5 mM malate concentration. To
compute this estimate, it was necessary to also consider the
pyruvate concentration. The pyruvate concentration was 2 mM;
however after 8 minutes of state 3 respiration, the pyruvate
utilization was 848 nmol/mg. Considering the 1 mL chamber
volume, this implied that the total initial pyruvate concentration
was 2.5–3.4 mM and not 2 mM. In an attempt to address these
potential data inconsistencies, the model simulations were fit to the
data using a mitochondrial load of 3.5 mg/mL and the reported
state 3 pyruvate utilizations were subsequently adjusted to be
consistent with an initial pyruvate concentration of 2 mM.
All mathematical models are abstractions of the underlying
process; the level of detail included in the model is dependent upon
the application. This is particularly true for the calcium dynamics
associated with mitochondrial bioenergetics. There are known
omissions in this and previous models of these calcium dynamics.
The mitochondrial Na+/Ca2+ dynamics were simulated using a
simplified Na+/Ca2+ cycling mechanisms with only the CaUNI,
mNCE and mNHE processes represented. This simplification
prohibited a mechanistic representation of the actual physiological
event. For example, the omission of the rapid mode of calcium
uptake (RAM) [49] process necessitated a high CaUNI influx to
reach the steady state calcium measurements (from the Wan data
set) within a few minutes of extra-mitochondrial calcium addition.
(Note, with this higher calcium influx rates, the model still predicts
the Na+/Ca2+ cycle consumes less than 1% of the proton
electrochemical gradient established by the ETS.) Also, the Na+independent calcium efflux mechanism is not included in the
model formulation since the underlying process is uncertain
(electroneutral or electrogenic [50–52]) even though it is estimated
to contribute up to 33% of total calcium efflux in heart tissue [53].
This omitted calcium efflux mechanism is insensitive to magnesium and prevented adequate fits to the Mg2+-titration data
presented in Wan et al.; however, Mg2+-dependence of the
CaUNI and mNCE did enable the simulations to reproduce the
reported steady state matrix calcium levels within a few 100 nM
(not shown). An explicit, detailed study of the Na+/Ca2+ dynamics
should be modeled under various experimental conditions to fully
characterize and understand this process at a more mechanistic
level.

model predicts that the cardiac mitochondrial bioenergetic
response to varying buffer osmolarity under the conditions
presented in Devin et al. would produce Dys in the range of
2200 to 2140 mV, DpH in the range of 7 to 30 mV (0.2 to
0.5 pH units) and MVO2 rates in the range of 200 to 15 nmolO/
mg/min.
The translation of the biochemical processes to appropriate
mathematically descriptive expressions plays a large role in the
simulated dynamics. For example, the citrate and isocitrate
overestimation by the model as shown in Figure 3C is attributed
to the simple passive exchange process used to model the
tricarboxylate carrier (TCC). Replacing this exchange process
with a more kinetically descriptive mechanism [47] would help
prevent the simulated early accumulation of citrate and isocitrate;
however, there is insufficient data to parameterize such a
descriptive mechanism. Partially as a function of the simplified
description, the activity of the TCC is elevated even though it is
reported to possess low activity in heart tissue compared to that in
liver tissue [41]. Additionally, the passive TCC exchange process
required higher PDH rates in order to sustain sufficient citrate,
isocitrate, a-ketoglutarate and succinate levels during both state 2
and especially state 3 respiration seen in Figure 3. Together, the
TCC and DCC modeling approximations contribute to the
simulated higher malate net oxidation rates than those observed in
the LaNoue data set (Figure 3F) since the TCC also exchanges
malate across the inner-mitochondrial membrane [47].
During the model development, it is important to consider any
artifacts in the experimental data that may have been inadvertently generated during the mitochondrial isolation. For example,
the extraction medium must contain Pi to achieve stable, wellcoupled mitochondria [41]. To enable the Bose study with Pidepleted mitochondria, a special isolation procedure was necessary. This Pi-depletion method may have dramatically changed
some of the mitochondrial protein phosphorylation states thus
having an unknown regulatory effect [48]. Within the short time
scales of the Bose experiments, the slower phosphorylation and
dephosphorylation events may not have sufficiently occurred upon
the Pi-titration. Specifically, the Pi-depletion method may have
altered the proton permeability via cation/proton exchange and/
or anion/proton cotransport activity. In these experiments, the
buffer pH was fixed at 7.1. With the mKHE rate expression
identical to that used with the other data sets, the simulated Dy is
underestimated while the DpH is overestimated, but the total
energetic contribution from both Dy and DpH was nearly
identical to that reported. This compensation results from their
thermodynamic equivalence with some important kinetic differences. To achieve the low DpH values reported experimentally,
the volume-dependent mKHE expression had to be replaced with
a high activity K+/H+ exchanger. It is postulated that the Pidepletion dramatically altered the proton permeability. This is
manifested in the model by essentially creating a high activity
rapid equilibrium exchanger mechanism that is not supported by
the volume-dependent mKHE expression. However, this high
activity K+/H+ exchanger is not compatible with the volume
dynamics presented in the Kowaltowski data set, so it is only used
for the Bose data set simulations since their isolation procedure
was done without Pi. Although we chose to address this
discrepancy using a high K+/H+ exchanger, there are several
alternative mechanisms that could also potentially describe or
contribute to the DpH discrepancy. For example, the mNHE
could be responsible for converting more of the DpH into the Dy
than the model predicted. It is possible the mNHE activity is
underestimated; however, the models ability to match the reported
steady state matrix free calcium concentration at varied buffer
PLoS Computational Biology | www.ploscompbiol.org
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and sensitivity analyses were done on a cluster of four 8-core Intel
Xeon 3.4 GHz CPUs each with 16 GB of memory and running
the Windows 2003 server platform using the Parallel Computing
Toolbox. The results obtained were displayed using MATLABH.

In summary, the model presented in this manuscript proposes
an extended mitochondrial bioenergetics model targeted at the
cardiac myocyte with the parameters estimated using four
independent data sets consisting of 32 data curves. It was capable
of fitting the data with good fidelity, had relatively little parameter
sensitivity relative to the experimental conditions modeled herein
and was capable of adequately modeling metabolic trends during
the various conditions simulated. The resulting model simulations
reproduce observed mitochondrial volume dynamics lending
additional support to the current prevailing theory of mitochondrial volume regulation through the mKHE volume-sensitive
exchange rate. The model builds upon previous successes and
helps refine and establish a global model framework relating to
mitochondrial bioenergetics. During the model development, a
certain network topology had to be in place and some assumptions
about uncertain or unobserved experimental factors and conditions were explicitly constrained to reproduce all the data sets.
Specifically, the effect of intrinsic thermodynamic dissipation of
the system on enzymatic regulation, importance of animal species
and tissue sources differences, mechanistic detail of the model and
potential impact of the experimental environment all help
constrain the model formulation contributing to the construction
of a successful and physiologically faithful model.
The model can serve as a foundation for further extension and
refinement efforts. Future work may consider more detailed and
mechanistic mathematical abstractions for the ETS and TCC,
Ca2+ dynamics including the RAM and Na+-independent Ca2+
efflux pathways, catabolic (i.e., glutamate dehydrogenase) and
anabolic (i.e., pyruvate carboxyalse) reactions and b-oxidation
pathways enabling integration into whole cell models of cardiac
myocytes. Each of these additions will require additional
experimental data taken under well controlled and documented
conditions in order to be properly reproduced by the model
proposed in this manuscript. For example, changing the passive
exchange mechanism of the TCC to a more mechanistic, saturable
exchange process should enable better fits to the LaNoue data set.
This change would keep matrix citrate and isocitrate at sufficient
levels to maintain a-ketoglutarate and succinate concentrations
experimentally observed allowing fumarate to be included in the
list of DCC substrates. With fumarate being removed from the
matrix by the DCC, SDH inhibition would be mitigated and the
lower branch of the TCA cycle would accelerate and prevent net
oxidation of malate observed in the LaNoue experimental data set.
Additionally, reproducing the respiratory control ratios as done in
silico by Korzeneiwski and Mazat [54] using the experimentally
measured respiratory control ratios measure by Rossignol et al.
[55] would help constrain, define and corroborate the mathematical abstractions for the ETS, F1FO, ANT and PYRH mechanisms. Experiment design with this model could further reduce
parameter uncertainties and help test alternative hypotheses
including some postulates made in the Discussion. Although much
work is ahead, we feel that this model takes a step towards a more
complete physiologically faithful mitochondrial bioenergetics
model.

Objective Function
The objective function used for parameterization of the model
is defined as

Nj,k 
Mk
X 1 X
yi,j,k ð pÞ{Yi,j,k 2
1 X
f ð pÞ~
Mk j~1 Nj,k i~1
si,j,k
k

where f is the objective function evaluated at a given parameter
point p, yi,j,k is the model output, either a state variable or
computed rate, corresponding to the ith experimental data point
in the jth experimental data curve for the kth data set evaluated at
the parameter point p, Yi,j,k is the ith experimental data point in
the jth experimental data curve for the kth data set, si,j,k is the
standard deviation for the ith experimental data point in the jth
experimental data curve for the kth data set, Nj,k is the number of
data points in the jth experimental data curve for the kth data set
and Mk is the number of data curves for the kth data set. When no
statistical data were given with the experimental data, a 5–10%
relative error was assumed.

Parameter Identification
Fitting such large, non-linear models to data with many
unknown parameters and initial conditions requires a robust
model structure and many independent data sets to appropriately
constrain the parameters. The model presented in this manuscript
consists of a total of 359 parameters. These parameters were
identified using three methods: i) 262 parameters were fixed
according to previously published values in the literature (see Part
S3 of the Supplemental Material (Text S1)), ii) 55 parameters were
found by minimizing the sum of the squares of the difference
between simulated rate expressions and the published data using
Equation 1 (see Part S3 of the Supplemental Material (Text S1)),
and iii) a custom parallelizable Monte Carlo optimization
algorithm based on simulated annealing was used to fit the
remaining 42 parameters by minimizing Equation 1 with
replicated experiments [8–11]. Global candidate points were first
identified using the simulated annealing approach and refined with
a local search using a gradient-based algorithm (MATLABH’s
fmincon function).

Sensitivity Analysis
The local sensitivity analysis was done using the absolute
normalized local sensitivity coefficient (LSC) for quantifying how
much the model output trajectories for the simulated experimental
conditions changed in response to small perturbations about the
identified parameter set. This LSC is defined as

LSC ð‘Þ~

Methods
Numerical Solutions


Nj,k 
Mk
Lyi,j,k
1X 1 X
1 X
p‘ 

ð
p
Þ
H k Mk j~1 Nj,k i~1  Lp‘
yi,j,k ð pÞ

ð2Þ

where LSC is the normalized local sensitivity coefficient for the ,th
parameter, yi,j,k is the model output of the ith state at the jth time
point for the kth experimental condition evaluated at the
parameter point p, p, is the parameter whose sensitivity is being
approximated, Nj,k is the number of states considered for the
analysis (note, all 73 states were included in the sensitivity analysis)
at the jth time point for the kth experimental condition, Mk is the

The DAEs describing the model were numerically integrated
using MATLABH (2008b) and the stiff ode solver ode15s (1023
relative tolerance and 1029 absolute tolerance for matrix and IMS
state variables and 1026 for all others). To increase computational
efficiency, vectorized functions were used during model development in the MATLABH environment. Parameter optimizations
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experimental conditions as described in each paper used for
parameter estimation.
Mitochondrial loads. Each experiment used different
mitochondrial loads; therefore, for each data set, the buffer
water volume relative to the mitochondrial protein content was
varied. This is important because the higher the mitochondrial
load, the higher the absolute rate of consumption for carbon
substrates and oxygen making time series data essential for
parameterization purposes. The Bose data set experiments were
performed at a mitochondrial load of 1 nmolCyta/mL, or
approximately 1 mg mitochondria/mL [58–59]. The LaNoue
data set experiments used a much larger mitochondrial load of
3–4 mg mitochondria/mL. The reported 3–4 mg mitochondria/
mL for the simulations was averaged (as mentioned in the
Discussion). The Wan data set experiments were performed at
2 mg mitochondria/mL. The Kowaltowski data set experiments
used a mitochondrial load of 0.1 mg mitochondria/mL. The
Devin data set experiments reported using 1 mg/mL; however, for
the experimental conditions imposed, the liver mitochondria
maintained relatively low MVO2 rates (approximately 100 nmol
O/min/mg) for the duration of the 10 minute experiment. For
identical conditions, the model simulates MVO2 rates greater than
three times this value; therefore, in order to maintain pseudosteady state conditions for 10 minutes, the mitochondrial load had
to be adjusted to 0.1 mg/mL. This prevented the model from
simulating considerable ADP consumption rates in order to
maintain steady MVO2 rates for 10 minutes.
Bose experimental conditions. Before simulating the
experimental conditions (T = 37uC) in the Bose data set, the
model had to be initialized to recreate the Pi-depleted state of the
mitochondria. This was done by simulating the model to its fully
oxidative state in the presence of ATP followed by a quick Pidepletion step. Unfortunately, the exact details concerning the Pidepletion protocol could not be found. For parameter estimation,
the basic buffer composition consisted of 125 mM KCl, 15 mM
NaCl, 20 mM K-Hepes, 1 mM KEGTA, 1 mM K2EDTA, 5 mM
MgCl, 4 mM TPP+ at pH 7.1. The authors stated that the free
[Ca2+] was generally held between 500 and 600 nM using CaCl2.
For simulation purposes, the free [Ca2+] was fixed at 550 nM. To
initiate respiration, 5 mM glutamate/malate was added to the
buffer preceding the Pi-titrations for the simulations. For state 3
respiration, 1.3 mM ADP was added to the medium after the
glutamate/malate and Pi additions. For each Pi-titration, the free
[K+], [Na+] and [Mg2+] were calculated based on the dissociation
constants defined in the Supplemental Material (Text S1). After
glutamate/malate was added to the buffer, the model simulated
the 60 second experiment reaching pseudo-steady state. Next, Pi
was added to the buffer and the model was simulated for the next
60 second experiment reaching another pseudo-steady state. To
conclude the experiment, ADP was added to the buffer and the
model was simulated for the 30 second experiment reaching its
final pseudo-steady state.
LaNoue experimental conditions. For the LaNoue data set
simulations (T = 28uC), the model was first initialized to achieve
the fully oxidized state. The basic buffer composition used for
respiratory state initiation consisted of 150 mM KCl, 20 mM TrisCl, 20 mM KPi, 5 mM MgCl2 and 30 mM glucose at pH 7.2.
The mitochondria were preincubated in the basic buffer
composition for 30 seconds before addition of substrates. For
state 2, either 2 mM pyruvate and 5 mM malate or 1 mM
pyruvate was added to the basic buffer composition, and the
model was simulated for the specified experimental time. (Note
that in the original reference, LaNoue et al. define state 4 as state 2
is defined in this manuscript. They used the previous state

time points used in the analysis (note, Mk was fixed and defined as
5 equally spaced time points) for the kth experimental condition
and H is the total number of experimental conditions replicated
from [8–11]. (Note that although the indices used for the LSC
computation are similarly defined, they have different meaning.)
Equation 2 was approximated using a centered finite difference
using the numerical methods outlined in Conn et al. [56]. To
minimize numerical artifacts when computing the LSCs, the
model was integrated with stricter tolerances (1029 relative
tolerance and 10212 absolute tolerance tolerance for matrix and
IMS state variables and 1029 for all others). This unit of measure is
used in Table 2 to discern the 1st order, one-at-a-time, effects of
small parameter perturbations. A parameter that possesses a large
LSC is interpreted as having a substantial influence on the model
state trajectories and steady state values.

Simulating the Experimental Conditions
To simulate the various data sets used to parameterize and
corroborate the model, the appropriate experimental conditions
were taken into consideration. The temperature at which the
experimental data were obtained, the mitochondrial loads applied
in each experiment, the initial state of the mitochondria in the
experimental system and the precise nature of the experimental
environment, specifically the buffer composition and osmolarity
were considered. These points are discussed below.
Temperature dependence. The rates of biochemical
reactions can be extremely sensitive to temperature. A
temperature induced change in activity can easily result in
doubling or even tripling of some enzymatic reactions for a
temperature difference of only 10uC. Since the experiments used
to parameterize the model were done at different temperatures,
the rates were adjusted according to a standard Q10 value of 2.25
or based specifically on the enzyme’s activation energy and the
Arrhenius rate law. The Arrhenius rate law temperature
correction is only truly valid for reactions whose substrates are
in rapid equilibrium with their respective substrate-enzyme
complexes, and the catalysis step is rate limiting [57]. This
becomes significant when dealing with convex Arrhenius plots.
The source of convexity is controversial and usually involves
different active substrate-enzyme isoforms at different
temperatures. We assumed that even though some of the
biochemical reactions in the model were not reactions whose
substrate-enzyme species were in rapid equilibrium, we could still
obtain a reasonable approximation of the temperature correction.
In the case of an enzymatic reaction displaying a convex Arrhenius
plot, only the linear region in the temperature range of 4–37uC
was used to adjust the rates. Table S1.3 in the Supplemental
Material (Text S1) shows the compiled list of activation energies
used in this model study.
Model initialization. It is especially important to use the
appropriate initial conditions by either including them in the
fitting procedure as variables or conditioning the model by
simulation to set common initial operating conditions. We chose
the latter and standardized the initial conditions by simulating the
model for sufficiently long times with the experimental conditions
outlined in each paper. For example, the Bose data set was derived
from de-energized, equilibrated mitochondria, the LaNoue data
set was derived from de-energized, non-equilibrated mitochondria,
the Wan data set was derived from energized, equilibrated
mitochondria, the Kowaltowski data set was derived from deenergized, non-equilibrated mitochondria and the Devin data set
was derived from energized, equilibrated mitochondria. Once the
model was simulated to its fully oxidized state, appropriate
modifications to state variables were performed to mimic the
PLoS Computational Biology | www.ploscompbiol.org
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DMO, 5 mM manitol, 20 mM Tris-HCl, 1 mM EGTA, 6 mM
Tris-glutamate, 6 mM Tris-malate, 5 mM Tris-Pi at pH 7.2 with
varying amounts of KCl used to adjust the osmolarity. The buffer
[K+] was approximated by setting it equal to half the reported
osmolarity. Since no divalent cation was present in the medium,
the adenylate kinase reaction was turned off. The model was
simulated under state 2 conditions until steady state was reached (a
simulated time of 5 minutes) under the varying osmotic conditions.
Then, at each osmotic condition, 1 mM of ADP was added to the
buffer and the model was simulated to a pseudo-steady state
reproducing the reported 10 minute experiments.

nomenclature defined by Chance and Williams [60]. The
definitions used here are consistent with those defined by
Nicholls and Ferguson [61]). State 3 was simulated similarly,
except for the addition of 0.5 mM ADP. With the addition of
ADP, the free [K+], [Na+] and [Mg2+] were recalculated based on
the dissociation constants defined in the Supplemental Material
(Text S1). A hexokinase trap was used to regenerate ADP in the
buffer. The simulated time was identical to that reported in the
experimental procedure.
Wan experimental conditions. The Wan Data set
simulations (T = 28uC) also required model initializations from a
fully oxidized state. The buffer composition consisted of 130 mM
KCl, 20 mM HEPES, 5 mM MgCl2, 5 mM ATP, 5 mM
KH2PO4, 5 mM NaCl and 1 mM EGTA at pH 7.0. For the
Na+- and Mg2+-titrations, the free [K+], [Na+] and [Mg2+] were
recalculated at each data point based on the dissociation constants
defined in the Supplemental Material (Text S1). ATP was included
to energize the mitochondria providing an electrophoretic driving
force for calcium uptake. The model simulated a 2 minute
experiment to ensure steady state and closely matches the time
observed in the original experimental procedure.
Kowaltowski experimental conditions. The Kowaltowski
data set simulations (T = 28uC) were simulated from a fully
oxidative and pre-osmotic equilibration state. The basic buffer
composition used for respiratory state initiation consisted of
135 mM KCl, 5 mM succinate, 2.5 mM Pi, 100 mM EGTA,
0.5 mM MgCl2 at pH 7.2. They applied various bioenergetic
pharmaceutical interventions and measured the matrix swelling
dynamics. To block the F1FO ATP synthase, 0.5 mg/ml
oligomycin was used. To simulate this condition, the parameter
F1 F0
defining the enzyme activity, Vmaxf
, was set to zero. When 30 mM
diazoxide, a mKATP channel opener, was used, the endogenous
inhibition of the mKATP channel was set to zero. When 300 mM
5-hydroxydecanoate, a mKATP channel closer, was used, the
parameter defining the channel conductance, GmKATP , was set to
zero. The simulated times are identical to the times reported in the
original experimental procedure.
Devin experimental conditions. For the Devin data set
simulations (T = 26uC), the model was first initialized to achieve
the fully oxidized state. The basic buffer composition used for
respiratory state initiation consisted of 5 mM TPMP+, 5 mM

Supporting Information
Text S1 The supplemental material consists of three parts. Part

S1 lists the state variables comprising the model, updated Gibbs
free energy of formation values, additional and revised dissociation
constants, temperature correction method, and general model
parameters. Part S2 introduces of the set of 60 non-linear ODEs,
five algebraic conservation expressions (for ATP, GTP, NADH,
UQH2 and c2+), five matrix cation ODEs (for H+, K+, Na+, Mg2+
and Ca2+) and the algebraic expressions for computing matrix and
intermembrane space (IMS) water volumes and matrix Cl2 is
presented. Part S3 discusses the model rate equation derivations
and provides all the associated parameter definitions and values.
Found at: doi:10.1371/journal.pcbi.1000632.s001 (2.73 MB
DOC)

Acknowledgments
We thank the reviewers for their comments that helped clarify and direct
the revision of this model. We would like to thank Robert Balaban for his
insightful communications regarding the model development. We would
also like to thank Jim Jones for computer assistance with the cluster and
Athurva Gore for preliminary work on the model presented in this
manuscript.

Author Contributions
Conceived and designed the experiments: JNB GTB AER. Performed the
experiments: JNB GTB AER. Analyzed the data: JNB GTB AER.
Contributed reagents/materials/analysis tools: JNB GTB AER. Wrote the
paper: JNB GTB AER.

References
11. Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD (2001) Bioenergetic
consequences of opening the ATP-sensitive K(+) channel of heart mitochondria.
Am J Physiol Heart Circ Physiol 280: H649–657.
12. Devin A, Guerin B, Rigoulet M (1997) Response of isolated rat liver mitochondria
to variation of external osmolarity in KCl medium: regulation of matrix volume
and oxidative phosphorylation. J Bioenerg Biomembr 29: 579–590.
13. Metelkin E, Goryanin I, Demin O (2006) Mathematical modeling of
mitochondrial adenine nucleotide translocase. Biophys J 90: 423–432.
14. Dash RK, Beard DA (2008) Analysis of cardiac mitochondrial Na+-Ca2+
exchanger kinetics with a biophysical model of mitochondrial Ca2+ handling
suggests a 3:1 stoichiometry. J Physiol 586: 3267–3285.
15. Garlid KD, Paucek P (2003) Mitochondrial potassium transport: the K(+) cycle.
Biochim Biophys Acta 1606: 23–41.
16. Hucho F, Randall DD, Roche TE, Burgett MW, Pelley JW, et al. (1972) -Keto
acid dehydrogenase complexes. XVII. Kinetic and regulatory properties of
pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase from
bovine kidney and heart. Arch Biochem Biophys 151: 328–340.
17. Qi F, Chen XW, Beard DA (2008) Detailed kinetics and regulation of
mammalian NAD-linked isocitrate dehydrogenase. Biochimica Et Biophysica
Acta-Proteins and Proteomics 1784: 1641–1651.
18. Mccormack JG, Denton RM (1979) Effects of Calcium-Ions and AdenineNucleotides on the Activity of Pig-Heart 2-Oxoglutarate Dehydrogenase
Complex. Biochemical Journal 180: 533–544.
19. Mcminn CL, Ottaway JH (1977) Studies on Mechanism and Kinetics of 2Oxoglutarate Dehydrogenase System from Pig Heart. Biochemical Journal 161:
569–581.

1. Wu F, Yang F, Vinnakota KC, Beard DA (2007) Computer modeling of
mitochondrial tricarboxylic acid cycle, oxidative phosphorylation, metabolite
transport, and electrophysiology. J Biol Chem 282: 24525–24537.
2. Nguyen MH, Dudycha SJ, Jafri MS (2007) Effect of Ca2+ on cardiac
mitochondrial energy production is modulated by Na+ and H+ dynamics.
Am J Physiol Cell Physiol 292: C2004–2020.
3. Cortassa S, Aon MA, O’Rourke B, Jacques R, Tseng HJ, et al. (2006) A
computational model integrating electrophysiology, contraction, and mitochondrial bioenergetics in the ventricular myocyte. Biophys J 91: 1564–1589.
4. Korzeniewski B, Zoladz JA (2001) A model of oxidative phosphorylation in
mammalian skeletal muscle. Biophys Chem 92: 17–34.
5. Nazaret C, Heiske M, Thurley K, Mazat JP (2009) Mitochondrial energetic
metabolism: a simplified model of TCA cycle with ATP production. J Theor Biol
258: 455–464.
6. Yugi K, Tomita M (2004) A general computational model of mitochondrial
metabolism in a whole organelle scale. Bioinformatics 20: 1795–1796.
7. Modre-Osprian R, Osprian I, Tilg B, Schreier G, Weinberger KM, et al. (2009)
Dynamic simulations on the mitochondrial fatty acid beta-oxidation network.
BMC Syst Biol 3: 2.
8. Bose S, French S, Evans FJ, Joubert F, Balaban RS (2003) Metabolic network
control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol
Chem 278: 39155–39165.
9. LaNoue K, Nicklas WJ, Williamson JR (1970) Control of citric acid cycle activity
in rat heart mitochondria. J Biol Chem 245: 102–111.
10. Wan B, LaNoue KF, Cheung JY, Scaduto RC Jr (1989) Regulation of citric acid
cycle by calcium. J Biol Chem 264: 13430–13439.

PLoS Computational Biology | www.ploscompbiol.org

15

January 2010 | Volume 6 | Issue 1 | e1000632

Modeling Mito. Bioenergetics with Volume Dynamics

41. Gnaiger E (2007) Mitochondrial Pathways and Respiratory Control. OROBOROS MiPNet Publications.
42. Tischler ME, Pachence J, Williamson JR, La Noue KF (1976) Mechanism of
glutamate-aspartate translocation across the mitochondrial inner membrane.
Arch Biochem Biophys 173: 448–461.
43. Saint-Macary M, Foucher B (1985) Comparative partial purification of the
active dicarboxylate transport system of rat liver, kidney and heart mitochondria.
Biochem Biophys Res Commun 133: 498–504.
44. Szewczyk A, Nalecz MJ, Broger C, Wojtczak L, Azzi A (1987) Purification by
affinity chromatography of the dicarboxylate carrier from bovine heart
mitochondria. Biochim Biophys Acta 894: 252–260.
45. Passarella S, Atlante A, Barile M, Quagliariello E (1987) Anion transport in rat
brain mitochondria: fumarate uptake via the dicarboxylate carrier. Neurochem
Res 12: 255–264.
46. Fleischer S, Rouser G, Fleischer B, Casu A, Kritchevsky G (1967) Lipid
composition of mitochondria from bovine heart, liver, and kidney. J Lipid Res 8:
170–180.
47. Bisaccia F, De Palma A, Prezioso G, Palmieri F (1990) Kinetic characterization
of the reconstituted tricarboxylate carrier from rat liver mitochondria. Biochim
Biophys Acta 1019: 250–256.
48. Hopper RK, Carroll S, Aponte AM, Johnson DT, French S, et al. (2006)
Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium.
Biochemistry 45: 2524–2536.
49. Buntinas L, Gunter KK, Sparagna GC, Gunter TE (2001) The rapid mode of
calcium uptake into heart mitochondria (RaM): comparison to RaM in liver
mitochondria. Biochim Biophys Acta 1504: 248–261.
50. Gunter TE, Chace JH, Puskin JS, Gunter KK (1983) Mechanism of sodium
independent calcium efflux from rat liver mitochondria. Biochemistry 22:
6341–6351.
51. Rottenberg H, Marbach M (1990) The Na(+)-independent Ca2+ efflux system in
mitochondria is a Ca2+/2H+ exchange system. FEBS Lett 274: 65–68.
52. Gunter KK, Zuscik MJ, Gunter TE (1991) The Na(+)-independent Ca2+ efflux
mechanism of liver mitochondria is not a passive Ca2+/2H+ exchanger. J Biol
Chem 266: 21640–21648.
53. Rizzuto R, Bernardi P, Favaron M, Azzone GF (1987) Pathways for Ca2+ efflux
in heart and liver mitochondria. Biochem J 246: 271–277.
54. Korzeniewski B, Mazat JP (1996) Theoretical studies on the control of oxidative
phosphorylation in muscle mitochondria: application to mitochondrial deficiencies. Biochem J 319 (Pt 1): 143–148.
55. Rossignol R, Malgat M, Mazat JP, Letellier T (1999) Threshold effect and tissue
specificity. Implication for mitochondrial cytopathies. J Biol Chem 274:
33426–33432.
56. Conn AR, Gould NIM, Toint PL (1987) Trust Region Methods: Society for
Industrial Mathematics.
57. Truhlar D, Kohen A (2001) Convex Arrhenius plots and their interpretation.
Proc Natl Acad Sci U S A 98: 848–851.
58. French SA, Territo PR, Balaban RS (1998) Correction for inner filter effects in
turbid samples: fluorescence assays of mitochondrial NADH. Am J Physiol 275:
C900–909.
59. Balaban RS, Mootha VK, Arai A (1996) Spectroscopic determination of
cytochrome c oxidase content in tissues containing myoglobin or hemoglobin.
Anal Biochem 237: 274–278.
60. Chance B, Williams GR (1956) Respiratory enzymes in oxidative phosphorylation. VI. The effects of adenosine diphosphate on azide-treated mitochondria.
J Biol Chem 221: 477–489.
61. Nicholls DG, Ferguson SJ (1992) Bioenergetics 2. London; San Diego, CA:
Academic Press. xvi, 255 p.

20. Panov A, Scarpa A (1996) Independent modulation of the activity of alphaketoglutarate dehydrogenase complex by Ca2+ and Mg2+. Biochemistry 35:
427–432.
21. Rodriguez-Zavala JS, Pardo JP, Moreno-Sanchez R (2000) Modulation of 2oxoglutarate dehydrogenase complex by inorganic phosphate, Mg(2+), and
other effectors. Arch Biochem Biophys 379: 78–84.
22. Dierks T, Riemer E, Kramer R (1988) Reaction mechanism of the reconstituted
aspartate/glutamate carrier from bovine heart mitochondria. Biochim Biophys
Acta 943: 231–244.
23. Murphy E, Coll KE, Viale RO, Tischler ME, Williamson JR (1979) Kinetics
and regulation of the glutamate-aspartate translocator in rat liver mitochondria.
J Biol Chem 254: 8369–8376.
24. Indiveri C, Capobianco L, Kramer R, Palmieri F (1989) Kinetics of the
reconstituted dicarboxylate carrier from rat liver mitochondria. Biochim Biophys
Acta 977: 187–193.
25. Indiveri C, Dierks T, Kramer R, Palmieri F (1989) Kinetic discrimination of two
substrate binding sites of the reconstituted dicarboxylate carrier from rat liver
mitochondria. Biochim Biophys Acta 977: 194–199.
26. Kramer R, Klingenberg M (1982) Electrophoretic control of reconstituted
adenine nucleotide translocation. Biochemistry 21: 1082–1089.
27. Barbour RL, Chan SH (1981) Characterization of the kinetics and mechanism of
the mitochondrial ADP-atp carrier. J Biol Chem 256: 1940–1948.
28. Duyckaerts C, Sluse-Goffart CM, Fux JP, Sluse FE, Liebecq C (1980) Kinetic
mechanism of the exchanges catalysed by the adenine-nucleotide carrier.
Eur J Biochem 106: 1–6.
29. Reeves JP, Condrescu M (2003) Allosteric activation of sodium-calcium
exchange activity by calcium: persistence at low calcium concentrations. J Gen
Physiol 122: 621–639.
30. Garlid KD (1990) New insights into mechanisms of anion uniport through the
uncoupling protein of brown adipose tissue mitochondria. Biochim Biophys Acta
1018: 151–154.
31. Jezek P, Mahdi F, Garlid KD (1990) Reconstitution of the beef heart and rat
liver mitochondrial K+/H+ (Na+/H+) antiporter. Quantitation of K+ transport
with the novel fluorescent probe, PBFI. J Biol Chem 265: 10522–10526.
32. Li XQ, Hegazy MG, Mahdi F, Jezek P, Lane RD, et al. (1990) Purification of a
reconstitutively active K+/H+ antiporter from rat liver mitochondria. J Biol
Chem 265: 15316–15322.
33. Garlid KD (2000) Opening mitochondrial K(ATP) in the heart–what happens,
and what does not happen. Basic Res Cardiol 95: 275–279.
34. Nowikovsky K, Schweyen RJ, Bernardi P (2009) Pathophysiology of mitochondrial volume homeostasis: Potassium transport and permeability transition.
Biochim Biophys Acta 1787: 345–350.
35. Garlid KD (1980) On the mechanism of regulation of the mitochondrial K+/H+
exchanger. J Biol Chem 255: 11273–11279.
36. Brierley GP, Jung DW (1990) Kinetic properties of the K+/H+ antiport of heart
mitochondria. Biochemistry 29: 408–415.
37. Territo PR, Mootha VK, French SA, Balaban RS (2000) Ca(2+) activation of
heart mitochondrial oxidative phosphorylation: role of the F(0)/F(1)-ATPase.
Am J Physiol Cell Physiol 278: C423–435.
38. Garlid KD, Dos Santos P, Xie ZJ, Costa AD, Paucek P (2003) Mitochondrial
potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in
cardiac function and cardioprotection. Biochim Biophys Acta 1606: 1–21.
39. Vander Heiden MG, Chandel NS, Li XX, Schumacker PT, Colombini M, et al.
(2000) Outer mitochondrial membrane permeability can regulate coupled
respiration and cell survival. Proc Natl Acad Sci U S A 97: 4666–4671.
40. Liu J (2006) Dissipation and maintenance of stable states in an enzymatic system:
analysis and simulation. Biophys Chem 120: 207–214.

PLoS Computational Biology | www.ploscompbiol.org

16

January 2010 | Volume 6 | Issue 1 | e1000632

